Ramelteon ( DrugBank: Ramelteon )

3 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2
8	Huntington disease	1
46	Malignant rheumatoid arthritis	1

6. Parkinson disease

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00907595 (ClinicalTrials.gov)	May 2009	20/5/2009	Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon	Treating Sleep Wake Cycle Disturbances in Basal Ganglia Neurodegenerative Disorder Subjects With Ramelteon- A Double Blind, Placebo Controlled Trial	Huntington's Disease;Parkinson's Disease;Dementia With Lewy Bodies;Sleep Disorders;Circadian Dysregulation	Drug: Ramelteon;Drug: Placebo	Massachusetts General Hospital	NULL	Withdrawn	20 Years	90 Years	Both	0	N/A	United States
2	NCT00462254 (ClinicalTrials.gov)	June 2007	16/4/2007	Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease	Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease	Parkinson's Disease	Drug: ROZEREM;Drug: Ramelteon	Southern California Institute for Research and Education	NULL	Terminated	45 Years	85 Years	Both	4	Phase 4	United States

Clinical trials : 242 / Drugs : 205 - (DrugBank : 62) / Drug target genes : 85 - Drug target pathways : 159

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00907595 (ClinicalTrials.gov)	May 2009	20/5/2009	Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon	Treating Sleep Wake Cycle Disturbances in Basal Ganglia Neurodegenerative Disorder Subjects With Ramelteon- A Double Blind, Placebo Controlled Trial	Huntington's Disease;Parkinson's Disease;Dementia With Lewy Bodies;Sleep Disorders;Circadian Dysregulation	Drug: Ramelteon;Drug: Placebo	Massachusetts General Hospital	NULL	Withdrawn	20 Years	90 Years	Both	0	N/A	United States

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000018816	2013/12/05	26/08/2015	Study on the relationship between arthritis and sleep disturbance	Study on the relationship between arthritis and sleep disturbance - Sleep study in arthritis	Rheumatoid Arthritis	Treatment with melatonin-mimetics, ramelteon. Treatment with biological disease-modifying anti-rheumatic drugs.	Shunichi Shiozawa	Rheumatic Diseases Center, Kohnan Kakogawa Hospital	Complete: follow-up complete	20years-old	Not applicable	Male and Female	200	Not applicable	Japan